Changes of hemodynamic and cerebral oxygenation after exercise in normobaric and hypobaric hypoxia: associations with acute mountain sickness by Kammerer, Tobias et al.
RESEARCH ARTICLE Open Access
Changes of hemodynamic and cerebral
oxygenation after exercise in normobaric
and hypobaric hypoxia: associations with
acute mountain sickness
Tobias Kammerer1,2,5* , Valentina Faihs1, Nikolai Hulde5, Andreas Bayer1, Max Hübner1,2, Florian Brettner1,2,
Walter Karlen4, Julia Maria Kröpfl3, Markus Rehm1, Christina Spengler3 and Simon Thomas Schäfer1,2
Abstract
Objective: Normobaric (NH) and hypobaric hypoxia (HH) are associated with acute mountain sickness (AMS) and
cognitive dysfunction. Only few variables, like heart-rate-variability, are correlated with AMS. However, prediction of
AMS remains difficult. We therefore designed an expedition-study with healthy volunteers in NH/HH to investigate
additional non-invasive hemodynamic variables associated with AMS.
Methods: Eleven healthy subjects were examined in NH (FiO2 13.1%; equivalent of 3.883 m a.s.l; duration 4 h) and
HH (3.883 m a.s.l.; duration 24 h) before and after an exercise of 120 min. Changes in parameters of electrical cardiometry
(cardiac index (CI), left-ventricular ejection time (LVET), stroke volume (SV), index of contractility (ICON)), near-infrared
spectroscopy (cerebral oxygenation, rScO2), Lake-Louise-Score (LLS) and cognitive function tests were assessed. One-Way-
ANOVA, Wilcoxon matched-pairs test, Spearman’s-correlation-analysis and Student’s t-test were performed.
Results: HH increased heart rate (HR), mean arterial pressure (MAP) and CI and decreased LVET, SV and ICON, whereas
NH increased HR and decreased LVET. In both NH and HH cerebral oxygenation decreased and LLS increased
significantly. After 24 h in HH, 6 of 11 subjects (54.6%) developed AMS. LLS remained increased until 24 h in HH,
whereas cognitive function remained unaltered. In HH, HR and LLS were inversely correlated (r = − 0.692; p < 0.05).
More importantly, the rScO2-decrease after exercise in NH significantly correlated with LLS after 24 h in HH (r = − 0.971;
p < 0.01) and rScO2 correlated significantly with HR (r = 0.802; p < 0.01), CI (r = 0.682; p < 0.05) and SV (r = 0.709;
p < 0.05) after exercise in HH.
Conclusions: Both acute NH and HH altered hemodynamic and cerebral oxygenation and induced AMS. Subjects,
who adapted their CI had higher rScO2 and lower LLS. Furthermore, rScO2 after exercise under normobaric conditions
was associated with AMS at high altitudes.
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Introduction
Acute hypoxia under both normobaric (NH) and hypo-
baric (HH) conditions is associated with symptoms of
acute mountain sickness (AMS) and cognitive dysfunc-
tion in humans [1–4]. The degree of hypoxemia plays a
central role in the pathophysiology of AMS [5]. How-
ever, decrease of peripheral oxygen saturation (SpO2)
under hypoxic conditions has previously been shown to
be of poor predictive value. Therefore, most publications
identified a combination of different variables to predict
AMS [6, 7]. Unfortunately, some of these variables are
difficult to raise under laboratory conditions or must be
measured invasively. Recently, heart rate variability
(HRV) was identified as a potential predictor for AMS in
healthy subjects, where the underlying mechanism is un-
clear [8]. Predicting the likelihood to develop AMS be-
fore ascent to HH could be important not only for
mountaineers but also for untrained individuals as im-
proved transport technologies allow to rapidly ascending
to high altitude. This exposes also persons with poten-
tially preexisting conditions like cardiovascular disorders
to an increased risk for AMS. It is therefore of particular
interest to find further non-invasive variables for AMS
prediction. Simultaneously, exposure to high altitudes is
associated with a decrease of cerebral oxygen saturation,
which is controversially discussed in terms of the inci-
dence of cognitive dysfunction [3, 9–11].
We therefore performed a study with healthy volunteers
to identify non-invasive variables under NH as predictors
for AMS. Using electrical cardiometry, near-infrared spec-
troscopy, cognitive function testing and Lake-Louis-Score
(LLS) we hypothesized that 1.) NH and HH would lead to
similar changes of hemodynamic variables, decreases in
systemic (SpO2) and cerebral oxygen saturation (rScO2)
and that 2.) hemodynamic changes and rScO2 in NH
would correlate with the degree of AMS in HH.
Materials and methods
Subjects and experimental protocol
After approval by the local Ethics Committee of the
University of Munich, Germany (project no. 350–16)
and obtaining written informed consent, 11 healthy fe-
male (n = 5) and male (n = 6) individuals aged 36.4 (±7)
years, with mean height of 178 (±6) cm and mean body
mass index of 22.7 (±2) kg/m2, were included in the
study. All subjects were in good physical and mental
condition, without any comorbidities or medication and
were measured at different time points in normobaric
normoxia, NH and HH (see Fig. 1). All individuals did
not stay at a height of more than 2000 m a.s.l. until at
least 6 weeks before the study.
The following protocol was done to evaluate effects of
hypobaric hypoxia: after initial baseline measurements in
Munich at 520 m a.s.l. (normoxia), all individuals were
transferred to Zermatt, Switzerland (1608 m a.s.l.) by car.
Next morning, ascent to Little Matterhorn at 3883 m a.s.l.
was done by cable car (duration 45 min), followed by fur-
ther measurements. After this, all subjects performed
Fig. 1 Experimental protocol for ascent and exercise in normobaric (hypoxic chamber) and hypobaric (Little Matterhorn summit) hypoxia
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120 min endurance exercise by descending to around
3500 m and reascending to 3883 m a.s.l.. Immediately
after physical exercise, measurements were performed in
an expedition tent (Keron 4 GT, Hilleberg AB, Frösön,
Sweden) on the glacier. After spending one night at
3883 m a.s.l. in the hut, measurements were performed
again 24 h after arrival at high altitude and repeated after
breathing 100% oxygen for 5 min (Fig. 1).
Additionally, 7 of these individuals (3 female, 4 male;
36.3 (±4) years; 179 (±6) cm; BMI 22.7 (±2) kg/m2) were
examined under normobaric conditions in a hypoxic
chamber (VPSA 16; Van Amerongen CA Technology,
Tiel, Netherlands) 6 weeks before (n = 4) and 6 weeks
after (n = 3) high altitude exposure. Again, baseline mea-
surements were performed in Munich at 520 m a.s.l. (nor-
moxia), followed by passive ascent (duration 45 min) to
simulated 3883 m a.s.l. in the hypoxic chamber and
120 min of endurance exercise at simulated 3883 m a.s.l.
including alternately cycling and walking with 15% slope
(Trac 3000 Tour Med and Crosstrainer 3000; Ergo-Fit
Inc., Pirmasens, Germany) (see Fig. 1). To simulate an alti-
tude of 3883 m a.s.l., participants were exposed to an in-
spiratory oxygen fraction of 13.1% at constant room
temperature (20–24 °C) and humidity (20–27%) for 4 h.
Acute mountain sickness score and cognitive
performance
Symptoms of AMS, consisting of headache, gastrointes-
tinal problems, insomnia, fatigue and dizziness, were
evaluated using a self-report questionnaire according to
the Lake Louise Score (LLS, 5 items, maximum point
sum 15) [12]. AMS after exposition to NH/HH was de-
fined as presence of moderate or severe headache in
combination with a LLS point sum of ≥3. Cognitive
function was evaluated on an Android tablet with a test
battery developed by the Mobile Health Systems Lab,
Eidgenössische Technische Hochschule (ETH), Zurich,
Switzerland, with a total of 4 different cognitive tests:
first, Trail Making Test A (TMT-A), where subjects
must connect numbers and Trail Making Test B
(TMT-B), where subjects must connect numbers and
letters in an ascending sequence (i.e. 1-A, 2-B, 3-C…) as
quickly as possible. Second, a target reaction test (tRT)
and a sorting reaction test (sRT) were performed. In the
tRT, one must keep a finger on a predefined area of the
tablet until a spot appears which should be touched as
quickly and accurately as possible. In the sRT, similar
looking geometrical forms must be quickly touched in
the order displayed above. For all cognitive tests, speed,
accuracy and response time were recorded electronically.
Subjects were asked to take 3 of each test type in an iso-
lated environment. Prior to the study, individuals trained
all tests to become familiar with the test battery and
handling of the tablet.
Cerebral oxygenation and advanced hemodynamic
monitoring
All variables regarding hemodynamics, peripheral oxy-
gen saturation and cerebral oxygenation were repeated
five-times at each time point to calculate mean values
for every subject. Heart rate, peripheral oxygen satur-
ation and non-invasive blood pressure were measured
with a mobile battery powered monitoring system (Infin-
ity® M540 Monitoring, Draeger Inc., Luebeck, Germany).
Cerebral oxygenation (rScO2) was measured using a
noninvasive near-infrared spectroscopy (NIRS) monitor
(INVOS™ 5100C Cerebral/Somatic Oximeter, Covidien
G, Boulder, CO, USA) powered by battery and a port-
able 240-V power converter. Non-invasive advanced
hemodynamic monitoring was performed with a port-
able monitor using electrical cardiometry (ICON™ Car-
diac Output Monitor, Osypka Medical GmbH, Berlin,
Germany) to measure cardiac index (CI), stroke volume
(SV), index of contractility (ICON) and left-ventricular
ejection time (LVET). This technique is based on varia-
tions of thoracic electrical bioimpendance due to
changes in thoracic conductivity during the heart cycle
registered by highly conductive sensors (Cardiotronic
Sensors™ Osypka Medical GmbH, Berlin, Germany) [13].
Statistical analysis
Normally distributed data are given as mean and stand-
ard deviation. In case of repeated measurements, a
one-way ANOVA with Greenhouse-Geisser correction,
followed by multiple comparisons with Bonferroni cor-
rection was performed (p < 0.05/n). Differences of LLS
were analyzed by Wilcoxon matched-pairs test. Correla-
tions were assessed using Spearman’s rank correlation
coefficients. T-test with Bonferroni-Sidak correction was
used to detect differences between groups after exercise.
All statistical analyzes were performed using PRISM ver-
sion 7 (GraphPad Software Inc., La Jolla, CA, USA).
Results
Compared to baseline, systemic and cerebral oxygen sat-
uration after exercise decreased significantly under nor-
mobaric and hypobaric conditions (NH: SpO2 97.7 ±
1.5% versus 82.9 ± 5.8%, p < 0.01; rScO2 73.7 ± 6.0% ver-
sus 62.0 ± 5.6%, p < 0.05; HH: SpO2 96.7 ± 1.0% versus
84.8 ± 4.9%, p < 0.001; rScO2 73.4 ± 8.3% versus 56.3 ±
11.0%, p < 0.001) (see Fig. 2a and b). After 24 h in hypo-
baric hypoxia 6 of 11 subjects (54.6%) developed AMS
(moderate or severe headache in combination with LLS
point sum ≥3). LLS point sum increased significantly
after exercise in NH and HH and highly significantly
after 24 h in HH compared to baseline measurements
(see Fig. 2c). However, cognitive function tests at either
NH or HH remained unchanged and did not correlate
with changes in hemodynamics, oxygen saturation or
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LLS. Comparing the four subjects with highest and low-
est LLS in HH, significant differences in rScO2 between
groups were revealed (p < 0.01; see Fig. 2d). During exer-
cise HR was 133.3 ± 16.9 min− 1 in NH compared to
142.8 ± 20.5 min− 1 in HH (p = 0.002). After exercise, HR
remained increased in both NH (61.6 ± 8.5 min− 1 versus
87.7 ± 7.8 min− 1; p < 0.01) and HH (61.1 ± 8.8 min− 1 ver-
sus 101.8 ± 6.8 min− 1; p < 0.001) compared to baseline
measurements, accompanied by a simultaneous decrease
of LVET whereas mean arterial pressure only increased in
hypobaric conditions (86.6 ± 5.4 mmHg versus 98.8 ±
8.9 mmHg; p < 0.05) compared to baseline (see Figs. 3a, b
and c). Cardiac index increased significantly after exercise
at high altitude (see Fig. 3d). Further values are given at
Table 1. In HH, a significant negative correlation was
found between HR and LLS (r = − 0.692; p < 0.05).
Additionally, after exercise, rScO2 correlated with HR
(r = 0.802; p < 0.01), CI (r = 0.682; p < 0.05) and SV
(0.709; p < 0.05). Furthermore, in HH, rScO2 after ex-
ercise showed an inverse correlation with LLS after
24 h (r = − 0.817; p < 0.01). Most importantly, reduced
rScO2 after exercise in NH was inversely correlated with
LLS after 24 h on the mountain (r = − 0.971; p < 0.01).
Discussion
Acute mountain sickness is an ongoing topic in high
altitude medicine. Until now, different variables with a
predictive value for AMS could be identified [6, 7]. Of
A B C D
Fig. 2 Peripheral and cerebral oxygen saturation and Lake Louise Score in normobaric (hypoxic chamber; n = 7) and hypobaric (Little Matterhorn
summit; n = 11) hypoxia. a Changes in pulse oximetry saturation (SpO2: %). b Changes in regional cerebral oxygen saturation (rScO2 % mean
values of right and left hemisphere). Statistical analysis for A and B using one-way repeated-measures ANOVA with Greenhouse-Geisser
correction, followed by multiple comparisons with Bonferroni correction. c Changes in Lake Louise Score (LLS: median and interquartile-range) for
evaluation of Acute Mountain Sickness. Subjects completed a self-reported questionnaire on a tablet. Statistical analysis using Wilcoxon matched-
pairs signed rank tests. d Comparison of regional cerebral oxygen saturation (rScO2: %; mean values of right and left hemisphere) between the four
subjects with lowest LLS and the four subjects with highest LLS after 24 h in hypobaric hypoxia. Statistical analysis using t-test with Bonferroni-Sidak
correction, difference between groups after exercise * p < 0.05, ** p < 0.01, *** p < 0.001 vs. baseline in Munich at 520 m; ° p < 0.05, °° p < 0.01, °°° p <
0.001 vs. prior time point
A B C D
Fig. 3 Hemodynamic variables in normobaric (hypoxic chamber; n= 7) and hypobaric (Little Matterhorn summit; n= 11) hypoxia. Statistical analysis using
one-way repeated-measures ANOVA with Greenhouse-Geisser correction, followed by multiple comparisons with Bonferroni correction. a Changes in heart
rate (HR; min− 1). b Changes in mean arterial pressure (MAP; mmHg). c Changes in left ventricular ejection time (LVET; ms). d Changes in cardiac index
(CI; l/min/m2). * p< 0.05, ** p< 0.01, *** p< 0.001 vs. baseline in Munich at 520 m; ° p< 0.05, °° p< 0.01, °°° p< 0.001 vs. prior time point; x p< 0.05
between corresponding time points in hypobaric and normobaric hypoxia (n= 7)
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high interest, Sutherland et al. have recently shown a
significant correlation between heart rate variability and
AMS, evaluated by LLS [8]. However, HRV can be of
limited value in subjects with cardiovascular comorbidi-
ties i.e. arrhythmias or ß-blocker intake. It is therefore of
interest to identify further predictive variables which can
be assessed easily even in remote areas. In our study we
were able to identify further hemodynamic variables as-
sociated with AMS. To the best of our knowledge, this is
the first trial using electrical cardiometry combined with
cerebral near-infrared spectroscopy in high altitude.
In detail, in our healthy volunteers we have seen signifi-
cant increases in HR, CI, SV and decreases in LVET,
ICON and cerebral oxygenation. Effects on hemodynamic
variables were most pronounced after exercise in both,
normobaric and hypobaric hypoxia at an altitude of
3883 m a.s.l.. In accordance to the results of Sutherland et
al. [8] we found a significant negative correlation between
HR and LLS in hypobaric conditions. However, variables
assessed in hypobaric conditions could only allow recom-
mendations to interrupt further ascent or to immediately
descend but they cannot provide predictive value. In con-
trast, associations between variables assessed in a safe nor-
mobaric training environment and the risk of developing
actual AMS at high altitude could help to predict the indi-
vidual’s risk for AMS. In this regard, we could show a
negative correlation between normobaric rScO2 decrease
after exercise and LLS after 24 h in hypobaric conditions
on the mountain. Due to the fact that our subjects were
the same under NH and HH, an association is likely.
Thus, the rScO2 decrease in simulated altitude in a nor-
mobaric chamber might serve as a predictive variable in
the future. This is interestingly due to the fact, that there
is actually an existing debate about the air equivalent
model, which points out, that NH and HH are two differ-
ent stimuli for AMS [14, 15]. In some previously pub-
lished trials, the severity of AMS was higher in HH than
in NH whereas the underlying mechanism is unclear
[16, 17]. Additionally, preacclimatization in HH can re-
duce severity of AMS whereas preacclimatization in
NH was less effective [18–21]. However, the main
factor affecting AMS seems to be acclimatization to
hypoxia. The role of hypoxia in AMS was also sup-
ported by our presented data. When focusing on the
four individuals with highest and lowest LLS, it turns
out that they had lowest / highest cerebral oxygenation
which supports the hypothesis, that oxygen delivery
and clinical symptoms are associated. Simultaneously,
the significant correlation between the rScO2 decrease
after exercise and corresponding cardiac index under-
lines the importance of adequate hemodynamic adapta-
tion to hypoxic conditions. Although this is not a new
finding, it is of interest that we have found associations
between short exercise in a hypoxic chamber and
symptoms of AMS in high altitude. Furthermore, sub-
jects who were able to adequately adapt their cardiac
index either by an increase of HR or SV, have shown
better cerebral oxygenation and lower LLS point sum.
Thus, rScO2 after exercise under normobaric hypoxia
could be a possible predictor for AMS at high altitude.
This could be interestingly due to the fact that access
to high altitude areas is getting easier even for subjects
with cardiovascular diseases exposing those individuals
at risk for AMS [22].
In contrast to the observed changes in hemodynamics
and oxygenation, the cognitive function tests used in this
trial did not reveal any changes. This is in some accord-
ance with the literature where results are inconsistent:
Asmaro et al. (2013) investigated cognitive dysfunction
in hypoxic conditions at a simulated altitude up to
7.620 m a.s.l. in healthy volunteers [2]. The authors were
able to detect impairments of cognitive performance in
this setting of extreme high altitude. Davranche et al.
(2016) studied brain oxygenation and cognitive function
during 4 days at an altitude of 4.350 m a.s.l. and detected
a reduction in terms of speed and accuracy in the early
phase of hypoxic exposure whereas the slowdown of reac-
tion time was not detectable anymore after 2 days at high
altitude [3]. However, Issa et al. (2016) found no signifi-
cant changes in overall cognitive performance during an
expedition to Mount Everest [23]. Also, Pramsohler et al.
(2017) described inconsistent finding regarding cognitive
Table 1 Parameters measured with noninvasive hemodynamic monitoring using Electrical Cardiometry
















24 h and O2
Cardiac index (l/min/m2) 2.8 ± 0.6 3.0 ± 0.3 3.6 ± 0.50 2.7 ± 0.9 3.0 ± 0.9 3.6 ± 0.8** 3.1 ± 0.7 2.8 ± 0.6
Cardiac output (l/min) 5.2 ± 0.8 5.6 ± 0.5 6.8 ± 0.8 5.0 ± 1.5 5.8 ± 1.6 6.9 ± 1.5 5.8 ± 1.4 5.3 ± 1.2
Stroke volume (ml) 84.3 ± 7.8 85.3 ± 7.6 76.5 ± 8.4 81.4 ± 14.0 74.1 ± 14.0 68.0 ± 10.7* 67.6 ± 13.5* 69.6 ± 13.6
Left ventricular ejection
time (ms)
303 ± 27 304 ± 11 267 ± 13 313 ± 12 281 ± 12*** 240 ± 16*** 264 ± 20*** 282 ± 19**
Index of contractility 68.8 ± 20.1 68.2 ± 8.0 53.1 ± 13.8 64.8 ± 22.6 50.0 ± 17.5 45.2 ± 17.1** 44.0 ± 15.2** 45.9 ± 13.6*
Values are presented as mean ± SD. Statistical analysis with one-way repeated-measures ANOVA with Greenhouse-Geisser correction, followed by multiple
comparisons with Bonferroni correction for multiple comparisons, *p < 0.05, **p < 0.01, ***p < 0.001 vs. baseline in Munich at 520 m
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function in subjects that slept at a simulated altitude of
5.500 m a.s.l. [1]. While the combined parameter of cogni-
tive- and motoric reaction time didn’t change, these au-
thors even found a correlation between lower SpO2 and
shorter cognitive reaction time. In summary, the data re-
garding hypoxia and cognitive function are contradictory.
One reason for this could be the fact that the tests applied
throughout the studies are not standardized and vary. In
any case, at this point, cognitive function tests are not as-
sociated with symptoms of AMS.
Our study has limitations: First, we only included
healthy volunteers and can only speculate that the cere-
bral oxygenation decrease in normobaric hypoxia would
be of predictive value in patients with decreased heart
rate variability. Secondly, due to the higher heart rate,
exercise intensity seems to be slightly higher in HH than
in NH. This is probably due to the fact that the exped-
ition on the glacier had not been carried out as originally
planned due to the weather conditions, but had to be
modified. Third, the set of cognitive function tests used
was insensitive to detect mild cognitive impairment.
Thus, in future studies, a larger set of more standardized
tests is recommended. However, our trial provides new
insights regarding the relation between hemodynamics,
cerebral oxygenation and LLS, and thus these variables
assessed in normobaric conditions might help to predict
AMS in high altitude.
Conclusion
Non-invasive hemodynamic variables and cerebral oxy-
genation after exercise in normobaric hypoxia seem to
be associated with the occurrence of acute mountain sick-
ness at high altitude. This could be particularly interesting
as a predictor for acute mountain sickness. The variables
described here for the first time should therefore be inves-
tigated further in high altitude including more healthy
participants as well as subjects with comorbidities.
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